16
2
3
↑16
↓2
—3
Evidence suggests Nicotine mayincreaseSmoking cessation.
13 studies (21 claims)
Moderate consensus
Study Claims
| Intervention | Direction | Endpoint | Type | Population | Dosage | Title |
|---|---|---|---|---|---|---|
| prescriptions for nicotine replacement therapy or other evidence-based interventions | Decreases - were comparatively low | smoking cessation | Human | CHD and stroke populations | Not specified | Investigating the association between recorded smoking cessation interventions and smoking cessation in people living with cardiovascular disease using UK general practice data. |
| vaporized nicotine products (VNPs) | Increases - aid smoking cessation | smoking cessation | Human | — | Pod device (40 mg/mL nicotine salt) and tank device (18 mg/mL freebase nicotine). | Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trial.cited 5× |
| vaporized nicotine products (VNPs) (pod and tank device) | Increases - evaluates the effectiveness | smoking cessation | Human | people who smoke daily, are interested in quitting and receive a government pension or allowance | Pod device (40 mg/mL nicotine salt) and tank device (18 mg/mL freebase nicotine). | Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trial.cited 5× |
| vaporized nicotine products (VNPs) | Increases - aid smoking cessation | smoking cessation | Human | priority group | Pod device (40 mg/mL nicotine salt) and tank device (18 mg/mL freebase nicotine). | Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trial.cited 5× |
| nicotine replacement therapy (NRT) | No effect - demonstrated limited success | long-term smoking cessation | Human | adolescents | Not specified | Nicotine replacement therapy as a smoking cessation tool for adolescents: an update. |
| nicotine replacement therapy (NRT) | Increases - are effective | smoking cessation | Human | — | Not specified | Effects of interventions to combat tobacco addiction: Cochrane update of 2021 to 2023 reviews.cited 1× |
| nicotine replacement therapy patches combined with fast acting forms like gum | Increases - are effective | smoking cessation | Human | — | Not specified | Effects of interventions to combat tobacco addiction: Cochrane update of 2021 to 2023 reviews.cited 1× |
| nicotine e-cigarettes | Increases - are effective | smoking cessation | Human | — | Not specified | Effects of interventions to combat tobacco addiction: Cochrane update of 2021 to 2023 reviews.cited 1× |
| nicotine e-cigarettes | Increases - similar magnitude of effects | smoking cessation | Human | — | Not specified | Effects of interventions to combat tobacco addiction: Cochrane update of 2021 to 2023 reviews.cited 1× |
| nicotine e-cigarettes | Increases - emerged as the most effective treatments | smoking cessation | Human | — | Not specified | Effects of interventions to combat tobacco addiction: Cochrane update of 2021 to 2023 reviews.cited 1× |
| nicotine replacement therapy (NRT) | Increases - effective | smoking cessation | Human | smokers | Not specified | Factors influencing perceptions of electronic cigarette and nicotine replacement therapy use among French smokers experiencing socioeconomic disadvantage: A latent class analysis. |
| nicotine replacement therapy | No effect - planned to use | smoking cessation | Human | patients planning to quit smoking | Not specified | Use of nicotine products and tobacco cessation in Swiss primary care: Cross-sectional data from the Sentinella network. |
| nicotine replacement therapy (NRT) | Decreases - poorer smoking cessation outcomes | smoking cessation outcomes | Human | females | Not specified | Smoking Cessation in Black Adults: Differences by Sex and Age. |
| nicotine replacement therapy (NRT) or cessation medications | No effect - had used | smoking cessation support | Human | people recently released from smoke-free prisons in Queensland, Australia | Not specified | Smoking cessation support preferences among people released from smoke-free prisons in Queensland, Australia. |
| nicotine replacement methods | No effect - used | smoking cessation | Human | patients | Not specified | Nursing interventions for smoking cessation in hospitalized patients: a systematic review.cited 19× |
| nicotine vaping | Increases - generally reported that vaping helped them quit smoking | smoking cessation | Human | participants | Not specified | Vaping to quit smoking: Qualitative study of people receiving opioid agonist treatment.cited 1× |
| nicotine vaping | Increases - mainly optimistic that it could help them and others quit smoking | smoking cessation | Human | this group | Not specified | Vaping to quit smoking: Qualitative study of people receiving opioid agonist treatment.cited 1× |
| Electronic nicotine delivery systems (ENDS) | Increases - are more effective than | nicotine replacement therapy (nicotine patches) for smoking cessation | Human | — | Not specified | Assessment of Respiratory Health Implications of Vaping: A Systematic Review of Toxicity Mechanisms and Adverse Effects of Electronic Nicotine Delivery Systems. |
| Electronic nicotine delivery systems (ENDS) | Increases - are more effective than nicotine replacement therapy (nicotine patches) for smoking cessation | smoking cessation | Human | pregnant women | Not specified | Assessment of Respiratory Health Implications of Vaping: A Systematic Review of Toxicity Mechanisms and Adverse Effects of Electronic Nicotine Delivery Systems. |
| Electronic nicotine delivery systems (ENDS) | Increases - are considered a viable option for | smoking cessation | Human | — | Not specified | Assessment of Respiratory Health Implications of Vaping: A Systematic Review of Toxicity Mechanisms and Adverse Effects of Electronic Nicotine Delivery Systems. |
| short-acting nicotine replacement therapy with varenicline | Increases - increases | smoking cessation rates | Human | — | 3% nicotine salt e-cigarettes (closed pod system, tobacco flavor) plus cytisine for 12 weeks. | Effectiveness of nicotine salt vapes, cytisine, and a combination of these products, for smoking cessation in New Zealand: protocol for a three-arm, pragmatic, community-based randomised controlled trial.cited 2× |